MannKind Corporation (NASDAQ: MNKD)
Today is the big day. At 9:30 am pacific time, MannKind will be giving a presentation at the Aegis Capital Corp. 2015 Growth Conference. There has been quite a bit of interest in the conference. If you’re interested in watching it, click here. We will also be offering live updates on this page as important information from the presentation becomes available.
9:30 am – The presentation has been delayed. It will be available shortly.
9:46 am – The presentation has started.
9:47 am – Will see a big online push and magazine advertising for Afrezza.
9:51 am – The direct to consumer advertising campaign is underway.
9:52 am – Working on regulatory approval for Afrezza outside of the United States. Expecting updates next year.
9:53 am – Larger cartridges have come off of the lines and are now available.
9:54 am – Technosphere expected to be used for fundamental advantages in other treatments. Occasionally talking to companies about licensing technosphere.
9:56 am – Pulmonary hypertension indications soon to come and other indications are on the way.
9:57 am – Burning cash at a much slower rate. Eliminating unnecessary functions.
9:57 am – Presentation audio is having a technical difficulty.
9:58 am – Audio is back!
9:59 am – Milestones are coming. Not at liberty to disclose information. $50 million milestone met $25 million milestone on the way.
9:59 am – Afrezza prescriptions are climbing. Consumer awareness is a major factor.
10:01 am – Sanofi arrangement is a profit share agreement: 65% / 35% split. Sanofi funds share of losses.
10:03 am – Copay card program reduces Afrezza copay costs for consumers.
10:03 am – The presentation has ended.
[Image Courtesy of AEGIS]